Project 1 is a continuation of investigations on the occurrence of the spectrum of neurodegenerative diseases that are highly prevalent on Guam. It has yet to be determined whether neurodegenerative diseases occur in this population as a consequence of a single exposure or are explained by a multi-factorial model, such as genetic predisposition with environmental modifiers. There has been a remarkable shift in the disease manifestations over the past 4 decades. This shift has been from predominantly amyotrophic lateral sclerosis (ALS) in the 1950s to predominantly Parkinson-dementia complex (PDC) and pure dementia (D) in the 1970-1980s. The incidence of ALS appeared to peak in the late 1950s and as a distinct disease has gradually declined during each subsequent decade. A similar pattern of decline for PDC which peaked in the mid to late 1960s has also been reported although other studies indicate that the rate may not have changed. Mean age of onset for both ALS and PDC have shown a 10 to 15 year increase over the past four decades. A recent comprehensive study has confirmed that, regardless of clinical manifestation, age, male gender, and living in the southern villages of Guam and on Rota continue to be risk factors for developing either ALS or PDC. The proposed investigation consists of two parts. One is a follow-up study of two previously well established cohorts with the target diseases. In this part the scientific goals are to determine if familial clustering of ALS/PDC is still prevalent and whether or not the incidence of ALS/PDC is continuing to decrease. In the second part, a casecontrols study, the hypothesis will be tested that consumption of native food, specifically fadang, is a risk factor related to the development of ALS/PDC. The results of these efforts may provide a basis for establishing a potential Biologic explanation for this unique occurrence of neurodegenerative diseases and may ultimately lead to specific intervention and preventive strategies. This will directly benefit the people of Guam who have suffered from this terrible burden for so long, and would provide a model for studying other age-related neurodegenerative disorders such as Alzheimer disease.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program Projects (P01)
Project #
5P01AG014382-02
Application #
6267706
Study Section
Project Start
1998-03-01
Project End
1999-02-28
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
2
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of California San Diego
Department
Type
DUNS #
077758407
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Dombroski, Beth A; Galasko, Douglas R; Mata, Ignacio F et al. (2013) C9orf72 hexanucleotide repeat expansion and Guam amyotrophic lateral sclerosis-Parkinsonism-dementia complex. JAMA Neurol 70:742-5
Brunden, Kurt R; Ballatore, Carlo; Lee, Virginia M-Y et al. (2012) Brain-penetrant microtubule-stabilizing compounds as potential therapeutic agents for tauopathies. Biochem Soc Trans 40:661-6
Lee, Virginia M-Y; Brunden, Kurt R; Hutton, Michael et al. (2011) Developing therapeutic approaches to tau, selected kinases, and related neuronal protein targets. Cold Spring Harb Perspect Med 1:a006437
Yu, Chang-En; Bird, Thomas D; Bekris, Lynn M et al. (2010) The spectrum of mutations in progranulin: a collaborative study screening 545 cases of neurodegeneration. Arch Neurol 67:161-70
Brunden, Kurt R; Ballatore, Carlo; Crowe, Alex et al. (2010) Tau-directed drug discovery for Alzheimer's disease and related tauopathies: a focus on tau assembly inhibitors. Exp Neurol 223:304-10
Crowe, Alex; Huang, Wenwei; Ballatore, Carlo et al. (2009) Identification of aminothienopyridazine inhibitors of tau assembly by quantitative high-throughput screening. Biochemistry 48:7732-45
Brunden, Kurt R; Trojanowski, John Q; Lee, Virginia M-Y (2009) Advances in tau-focused drug discovery for Alzheimer's disease and related tauopathies. Nat Rev Drug Discov 8:783-93
Snyder, L R; Cruz-Aguado, R; Sadilek, M et al. (2009) Lack of cerebral bmaa in human cerebral cortex. Neurology 72:1360-1
Choi, Yoonha; Wijsman, Ellen M; Weir, Bruce S (2009) Case-control association testing in the presence of unknown relationships. Genet Epidemiol 33:668-78
Sieh, Weiva; Choi, Yoonha; Chapman, Nicola H et al. (2009) Identification of novel susceptibility loci for Guam neurodegenerative disease: challenges of genome scans in genetic isolates. Hum Mol Genet 18:3725-38

Showing the most recent 10 out of 53 publications